Immunocore Limited recalled 7,572 vials of KIMMTRAK injection on June 10, 2025. The affected lots may not provide the intended therapeutic effect. Consumers and healthcare providers should stop using the product immediately.
Subpotent Drug
Consumers and healthcare providers should stop using this product immediately. Contact IMMUNOCORE, LLC or your healthcare provider for guidance. Notification method: N/A
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The KIMMTRAK injection is a 100 mcg/0.5 mL solution for intravenous infusion after dilution. It was sold under NDC 80446-0401-01, with specific lot numbers 3D009AA09, 3D009AA10, 3D009AA25, and 3D009AA02. The product is manufactured in Denmark and was distributed nationwide.
The recall was initiated due to the drug being subpotent, meaning it may not deliver the intended dosage or therapeutic effect. This classification falls under Class II, indicating a high hazard level.
No specific injuries or incidents have been reported related to this recall. However, the potential for inadequate treatment poses a significant risk to patients.
Consumers and healthcare providers must stop using KIMMTRAK immediately. Contact Immunocore, LLC or consult with your healthcare provider for further guidance.
For more information, contact Immunocore at the customer service number provided on their official website.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.